Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 510
Selected: 0
NCT IDTitle
NCT03420079A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation
NCT04286503The Clinical Study of Carrimycin on Treatment Patients With COVID-19
NCT03351062Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
NCT05523960Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer Surgery
NCT06345287Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
NCT02053948Pursestring Wound Closure vs "Gunsight" Skin Incision and Closure Technique to Reverse Stoma
NCT07378683A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery
NCT01863485Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China
NCT04879654Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery
NCT05283616Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer
NCT05331326A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of PAM Pathway
NCT04099589Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma
NCT02527057Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer
NCT04718909Regorafenib Plus Sintilimab vs. Regorafenib as the Second-line Treatment for HCC
NCT06136026Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer
NCT06959732Zanubrutinib Combined With G-CVP in Previously Untreated FL
NCT02361112Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer
NCT03381430Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR
NCT07187154The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy
NCT00714077Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer
NCT07189572Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma
NCT07083375A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.
NCT06857305Efficacy and Safety of Biweekly Regimen of Eribulin Versus a Standard Regimen for the Treatment of Locally Recurrent or Metastatic HER2-negative Breast Cancer: a Multicenter, Randomized, Open-label, Phase III Trial
NCT07298239An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT03014102Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation
NCT06509490NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
NCT07306390Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND)
NCT05762900Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
NCT06833216Familial Breast Cancer in China
NCT02858206Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
NCT01492543Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer
NCT06544668A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
NCT04821843Neoadjuvant Treatment Modalities in Esophageal Cancer
NCT07364357A Phase I Study of CREPT-618 in Locally Advanced HCC
NCT07349160Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
NCT05886439LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer
NCT07019337Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer
NCT06667622Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy
NCT06146946Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
NCT06490107Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC
NCT03383562Daytime Variation of Complication in Gastric and Pancreatic Surgery
NCT06842472PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer
NCT07352280Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer
NCT01829841A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer
NCT07110090Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)
NCT07013461International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
NCT06035250AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
NCT02883374Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety
NCT0627718068Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
NCT01492556Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer